2015
DOI: 10.1016/j.cardfail.2015.06.111
|View full text |Cite
|
Sign up to set email alerts
|

Telomere Length as a Biomarker and Potential Contributor of Heart Failure Progression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Telomere shortening has been suggested to be susceptible to age-related cardiovascular diseases, including atherosclerosis and heart failure [5,7]. Many studies have shown that LTL predicts cardiovascular disease and all-cause mortality [27][28][29][30].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Telomere shortening has been suggested to be susceptible to age-related cardiovascular diseases, including atherosclerosis and heart failure [5,7]. Many studies have shown that LTL predicts cardiovascular disease and all-cause mortality [27][28][29][30].…”
Section: Discussionmentioning
confidence: 99%
“…The shortening of telomere length has been found to be common with age in the majority of tissues and cells; thus, it is often used as a biomarker of aging [4]. Research efforts have argued that leukocyte telomere length (LTL) shortening is related to a variety of cardiovascular diseases, including atherosclerosis, left ventricular hypertrophy, and heart failure, but the relevance to AF is still controversial [5][6][7]. In the Cardiovascular Health Study, researchers found no relationship between mean telomere length and AF in human atrial tissue [8].…”
Section: Introductionmentioning
confidence: 99%